News on Medial

Biotech startup Ahammune Biosciences raises $5 Mn led by pi Ventures

EntrackrEntrackr · 1y ago
Biotech startup Ahammune Biosciences raises $5 Mn led by pi Ventures
Medial

Biotech startup Ahammune Biosciences has raised $5 million in Series A funding round led by pi Ventures. The round also witnessed participation from Capital2B, Colossa Ventures, Bipin Agarwal, Unicornus Maximus LLP, and existing investors Ideaspring Capital, Kotak Alternate Assets, Legacy Assets LLP and IAN. The Pune-based company had previously raised around $3 million from its existing investors and others. The fresh fund will be used to conduct Phase II human clinical trials for drug candidates for vitiligo, expand the patent portfolio, and advance Ahammune’s R&D efforts for other immune-mediated skin diseases, Ahammune Biosciences said in a press release. Co-founded in 2016 by Parul Ganju and Krishnamurthy Natarajan, Ahammune Biosciences is a clinical-stage therapeutics company which aims to create innovative solutions to treat and cure skin diseases. With a focus on chronic skin conditions, it leverages its proprietary small molecule therapeutics platform to target and enhance skin health. The company intends to deliver cost-effective innovative treatments that address unmet needs in dermatology, advancing the future of skin disease therapies. According to Ahammune, its initial program is focused on developing a new drug candidate for vitiligo. It claims that its small molecule drug candidate does not cause generalized immunosuppression and has a first-in-class mechanism of action, with an ability to not only stop patch spread, but also stimulate the function of color producing cells in skin, thereby inducing repigmentation. In addition to vitiligo, Ahammune is developing a pipeline of patented molecules to treat other dermatological and autoimmune diseases. It aspires to expand its patent portfolio around its proprietary technology – the small molecule therapeutics platform, with a focus on treating skin conditions by targeting key cellular processes that influence skin health and immunity. The company is also seeking partnerships with pharmaceutical companies to co-develop the assets to maximize reach and commercial potential.

Related News

Deep-tech robotics startup Armatrix raises $2.1 Mn led by pi Ventures

EntrackrEntrackr · 21m ago
Deep-tech robotics startup Armatrix raises $2.1 Mn led by pi Ventures
Medial

https://entrackr.com/snippets/deep-tech-robotics-startup-armatrix-raises-21-mn-led-by-pi-ventures-11152392 Deep-tech robotics startup Armatrix raises $2.1 Mn led by pi Ventures The proceeds will be used to complete the development of its proprietary snake-like flexible robotic arm technology, expand the engineering and R&D team, and accelerate pilot deployments. Deep tech robotics startup Armatrix has raised $2.1 million in a pre-seed funding round led by pi Ventures, with participation from Inuka Capital, Boundless Ventures, Boost VC, Turbostart, and returning investor gradCapital. The proceeds will be used to complete the development of its proprietary snake-like flexible robotic arm technology, expand the engineering and R&D team, and accelerate pilot deployments with industrial customers, the company said in a press release. Co-founded in 2024 by Vishrant Dave, Prateesh Awasthi, and Ayush Ranjan, Armatrix develops snake-like, hyper-redundant robotic manipulators designed to operate in hazardous and confined industrial environments. The Bengaluru-based company aims to automate operations in hazardous and confined environments across sectors such as shipbuilding, nuclear, oil and gas, and aviation, where fatal injuries related to confined space work have been reported. Inspection and maintenance of critical infrastructure such as storage and fuel tanks, hulls, and reactors often require human entry into dangerous spaces. According to market research, the global robotics maintenance market was valued at $41.66 billion in 2023 and is projected to reach $150 billion by 2032. Armatrix's core technology focuses on reachability and actuation systems. Its robotic arm features high flexibility for seamless navigation, modular end effectors, and an AI-based navigation system that enables real-time adaptability. "Our mission is to move from a reactive, high-cost maintenance model to a proactive, zero-downtime standard, creating a paradigm shift in industrial inspection and maintenance. This funding enables us to scale from proof of concept to early adopters and validate the platform across real-world inspection and operational use cases," said Vishrant Dave, co-founder and CEO of Armatrix Automations. Looking ahead, Armatrix aims to emerge as a globally competitive deep tech robotics company, building AI-native, high-performance robotic systems that set new benchmarks in safety, precision, and efficiency for mission-critical industrial operations.

Download the medial app to read full posts, comements and news.